Onivyde 43mg Injection is a pharmaceutical preparation containing PEGYLATED LIPOSOMAL IRINOTECAN as its active ingredient, classified under the Anti Cancer general category and the Oncology speciality domain. Pegylated liposomal irinotecan is a topoisomerase I inhibitor encapsulated in a liposomal formulation, which increases circulation time and preferentially delivers the drug to tumour tissue, causing DNA damage and cancer cell death. Manufactured by SERVIER INDIA PRIVATE LIMITED. As with any prescription medicine, dosage and treatment duration must be individualised by the treating specialist based on the patient's diagnosis, disease stage, organ function, and concurrent medications.

Uses of Onivyde 43mg Injection
Used, usually in combination with fluorouracil and leucovorin, for the treatment of metastatic pancreatic cancer after prior gemcitabine-based therapy.

Onivyde 43mg Injection containing PEGYLATED LIPOSOMAL IRINOTECAN works as described: Pegylated liposomal irinotecan is a topoisomerase I inhibitor encapsulated in a liposomal formulation, which increases circulation time and preferentially delivers the drug to tumour tissue, causing DNA damage and cancer cell death. Therapeutically, it is classified under the Anti Cancer category and Oncology speciality domain. Regular monitoring by the treating specialist is recommended to assess treatment response and manage side effects.

• Always inform your doctor about every medicine, supplement, or herbal product you are currently taking before starting Onivyde 43mg Injection. Strong CYP3A4/UGT1A1 inhibitors or inducers can significantly alter drug levels and toxicity; caution with other myelosuppressive drugs.

Onivyde 43mg Injection is available under medical guidance and should be used strictly as advised by a licensed specialist. Storage: Store between 2°C and 8°C. Do not freeze. Protect from light. Disposal: Do not flush unused product or dispose of it in household waste; return unused or expired product to a licensed pharmacy. Manufactured by SERVIER INDIA PRIVATE LIMITED and complies with applicable regulatory standards.